Publications by authors named "Michael Erbach"

Claim this Profile
A
A New Optimized Percutaneous Access System for CIPII.
Rosa Garcia-Verdugo, Michael Erbach, Oliver Schnell

J Diabetes Sci Technol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for Outcome Scenario Analysis of Clinical Trials in Diabetes.
Rosa Garcia-Verdugo, Michael Erbach, Oliver Schnell

J Diabetes Sci Technol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge.
Michael Erbach, Guido Freckmann, Rolf Hinzmann, Bernhard Kulzer, Ralph Ziegler

J Diabetes Sci Technol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect?
Eberhard Standl, Michael Erbach, Oliver Schnell

Curr Treat Options Cardiovasc Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
Oliver Schnell, Michael Erbach

J Diabetes Sci Technol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the potential of acarbose to reduce cardiovascular disease.
Eberhard Standl, Michael J Theodorakis, Michael Erbach, Oliver Schnell, Jaakko Tuomilehto

Cardiovasc Diabetol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the analytical performance of systems for self-monitoring of blood glucose: concepts of performance evaluation and definition of metrological key terms.
Oliver Schnell, Rolf Hinzmann, Bernd Kulzer, Guido Freckmann, Michael Erbach

J Diabetes Sci Technol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defending the con side: obesity paradox does not exist.
Eberhard Standl, Michael Erbach, Oliver Schnell

Diabetes Care· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects.
Oliver Schnell, Michael Erbach, Eva Wintergerst

J Diabetes Sci Technol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic control: a combination of lifestyle management and the use of drugs.
Eberhard Standl, Michael Erbach, Oliver Schnell

Cardiol Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and Cons.
Eberhard Standl, Michael Erbach, Oliver Schnell

Diabetes Metab Res Rev· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
Oliver Schnell, Michael Erbach, Michael Hummel

Diab Vasc Dis Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and the risk for colorectal cancer.
Michael Erbach, Hellmut Mehnert, Oliver Schnell

J Diabetes Complications· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Exocrine pancreatic insufficiency and diabetes].
Philip D Hardt, Michael Erbach, Oliver Schnell

MMW Fortschr Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis